Portola Pharmaceuticals

- NASDAQ:PTLA
Last Updated 2021-07-30
  • Portola Pharmaceuticals develops therapeutics for acute and chronic cardiovascular, and autoimmune and inflammatory diseases.
  • Locations

    • South San Francisco CA
  • Total Funding (USD)

    149.0 million
  • Industries

    Mobile Apps, Cyber Security
  • Security

    Type: ORD
    CUSIP: 737010108
    ISIN: US7370101088
Filter date
All
Bookmark Created by Last updated
There were no results found.
Filter date
All
Article Author Published
There were no results found.

Request a demo to view additional historical data, and much more.